Immunogenicity-Guided Design of an Acinetobacter baumanii Vaccine

Area of Science:

• Vaccinology
• Nanotechnology
• Infectious Diseases

Background:

• Multidrug-resistant Acinetobacter baumannii poses a significant threat to public health.
• Developing safe and effective vaccines is crucial for controlling A. baumannii infections.

Purpose of the Study:

• To design and evaluate a dendritic cell (DC)-targeting multiepitope peptide-based biomimetic nanovaccine against A. baumannii.
• To assess the immunogenicity and protective efficacy of the nanovaccine in a murine model.

Main Methods:

• Bioinformatics tools were used to identify B- and T-cell epitopes from A. baumannii OmpW protein.
• A multiepitope peptide (rOmpW) was synthesized and encapsulated in neutrophil membrane-coated PLGA nanoparticles.
• The nanovaccine surface was functionalized with a DC-targeting peptide (DCpep).

Main Results:

• The biomimetic nanovaccine (DCpep-NM-PLGA-rOmpW) induced strong Th1 and Th17 cellular immune responses.
• Humoral immunity was significantly enhanced.
• The nanovaccine demonstrated substantial protective efficacy against lethal A. baumannii pneumonia in mice.

Conclusions:

• The developed biomimetic nanovaccine shows translational potential as a prophylactic strategy against A. baumannii infections.
• Targeting DCs with multiepitope peptide nanovaccines is a promising approach for combating MDR bacterial infections.